ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) for NOVO NORDISK
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
BUD: Budget matters relating to the National Diabetes Prevention Program, HHS, CMS, FDA, and NIH, generally; H.R. 3660 - To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings PHR: Issues relating to the 340B Drug Pricing Program; 21st Century Cures Act (H.R. 6); Innovation for Healthier Americans (Senate) MMM: Treat and Reduce Obesity Act (H.R. 2404/S. 1509); Medicare Diabetes Prevention Act (H.R. 2102/S. 1131); Medicare reimbursement issues, generally HCR: Issues involving the FFDCA, including the various user fee acts; FDASIA; and the BPCIA
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN E IRIZARRY New | Counsel, House Energy & Commerce Committee; Counsel, Senate Special Committee on Aging; Counsel, Senate HELP; Counsel, Senator Chuck Hagel |
| ISRAEL S KLEIN New | Deputy Staff Director, Joint Economic Committee, Chairman Chuck Schumer; Senior Communications Advisor, Representative Ed Markey; Communications Director, Senator Chuck Schumer; Press Secretary and Legislative Assistant, Representative Ed Markey |
| VINCENT A. ROBERTI, SR. New | — |
Medicare/Medicaid MMM
BUD: Budget matters relating to the National Diabetes Prevention Program, HHS, CMS, FDA, and NIH, generally; H.R. 3660 - To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings PHR: Issues relating to the 340B Drug Pricing Program; 21st Century Cures Act (H.R. 6); Innovation for Healthier Americans (Senate) MMM: Treat and Reduce Obesity Act (H.R. 2404/S. 1509); Medicare Diabetes Prevention Act (H.R. 2102/S. 1131); Medicare reimbursement issues, generally HCR: Issues involving the FFDCA, including the various user fee acts; FDASIA; and the BPCIA
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN E IRIZARRY New | Counsel, House Energy & Commerce Committee; Counsel, Senate Special Committee on Aging; Counsel, Senate HELP; Counsel, Senator Chuck Hagel |
| ISRAEL S KLEIN New | Deputy Staff Director, Joint Economic Committee, Chairman Chuck Schumer; Senior Communications Advisor, Representative Ed Markey; Communications Director, Senator Chuck Schumer; Press Secretary and Legislative Assistant, Representative Ed Markey |
| VINCENT A. ROBERTI, SR. New | — |
Budget/Appropriations BUD
BUD: Budget matters relating to the National Diabetes Prevention Program, HHS, CMS, FDA, and NIH, generally; H.R. 3660 - To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings PHR: Issues relating to the 340B Drug Pricing Program; 21st Century Cures Act (H.R. 6); Innovation for Healthier Americans (Senate) MMM: Treat and Reduce Obesity Act (H.R. 2404/S. 1509); Medicare Diabetes Prevention Act (H.R. 2102/S. 1131); Medicare reimbursement issues, generally HCR: Issues involving the FFDCA, including the various user fee acts; FDASIA; and the BPCIA
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN E IRIZARRY New | Counsel, House Energy & Commerce Committee; Counsel, Senate Special Committee on Aging; Counsel, Senate HELP; Counsel, Senator Chuck Hagel |
| ISRAEL S KLEIN New | Deputy Staff Director, Joint Economic Committee, Chairman Chuck Schumer; Senior Communications Advisor, Representative Ed Markey; Communications Director, Senator Chuck Schumer; Press Secretary and Legislative Assistant, Representative Ed Markey |
| VINCENT A. ROBERTI, SR. New | — |
Pharmacy PHA
BUD: Budget matters relating to the National Diabetes Prevention Program, HHS, CMS, FDA, and NIH, generally; H.R. 3660 - To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings PHR: Issues relating to the 340B Drug Pricing Program; 21st Century Cures Act (H.R. 6); Innovation for Healthier Americans (Senate) MMM: Treat and Reduce Obesity Act (H.R. 2404/S. 1509); Medicare Diabetes Prevention Act (H.R. 2102/S. 1131); Medicare reimbursement issues, generally HCR: Issues involving the FFDCA, including the various user fee acts; FDASIA; and the BPCIA
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN E IRIZARRY New | Counsel, House Energy & Commerce Committee; Counsel, Senate Special Committee on Aging; Counsel, Senate HELP; Counsel, Senator Chuck Hagel |
| ISRAEL S KLEIN New | Deputy Staff Director, Joint Economic Committee, Chairman Chuck Schumer; Senior Communications Advisor, Representative Ed Markey; Communications Director, Senator Chuck Schumer; Press Secretary and Legislative Assistant, Representative Ed Markey |
| VINCENT A. ROBERTI, SR. New | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| NOVO NORDISK US IS WHOLLY-OWNED BY NOVO NORDISK A/S | Denmark | Denmark | 100.0% | — |
| NOVO A/S (OWNS 26.5% OF NN A/S) | Denmark | Denmark | 26.0% | — |
| CLIENT IS WHOLLY-OWNED SUBSIDIARY OF NOVO NORDISK US | Denmark | Denmark | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.